BioStack Platforms
YC X26 · Active · Real world training envs for healthcare AI models
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
 83 SciencesShared: experimental data, discovery, labsActiveAI | AI | Active | YCS26 |
 OrbionShared: drug discovery, model, proprietaryNot statedAI | AI | Not stated | Antler2024 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
 Synthetic SciencesShared: training environment, model, slowActiveDevtools | Devtools | Active | YCW26 |
 DeeplifeShared: drug discoveryNot statedOther | Other | Not stated | EF2019 |
 DevFlightShared: data pipelineInactiveData, Devtools | Data, Devtools | Inactive | YCW19 |
 Mundo AIShared: high quality, training, modelActiveAI, Devtools | AI, Devtools | Active | YCW25 |
 HalluminateShared: high quality, training, modelActiveAI | AI | Active | YCS25 |
Also from X26 in AI
All of X26| Company | Category | Status |
|---|---|---|
 AbInitio BioThe Intelligence layer for Drug ManufacturingActiveAI | AI | Active |
 Advanced Metal ResearchMachine intelligence for American WeldingActiveAI | AI | Active |
 AgentPhonePhone Numbers for AI AgentsActiveAI | AI | Active |
 AkkariAutonomous Customer OperationsActiveAI | AI | Active |
 AllowanceThe spend control layer for AI agentsActiveAI | AI | Active |
 AmborasAI Native ShopifyActiveAI, Data, Devtools | AI, Data, Devtools | Active |
Founders
- Sanat MishraFounder/CEO
- Parth PatwaFounder/CTO
About BioStack Platforms
BioStack is building the data engine for healthcare and drug discovery AI. The bottleneck is not models. It is access to high-quality biological data. Clinical and experimental data is fragmented, unstructured, and locked inside hospitals, labs, and CROs, while generating new data is slow and expensive. BioStack fixes this with proprietary clinical and preclinical data pipelines that turn real biomedical workflows into ML-ready training environments. We structure longitudinal multimodal data across imaging, EHR, and experimental assays, then package it for post-training and reinforcement learning so models can learn how research and care actually happen. Instead of static datasets, BioStack gives AI labs workflow-aligned data and environments that improve reasoning, decision-making, and real-world performance in biology and medicine.
- YC batch
- X26 · Spring 2026
- Status, per YC
- Active
- Category
- AI, Data
- Team size
- 9
- Location
- San Francisco, CA, USA
- Founded
- 2025
- Checked
- 1h ago
BioStack Platforms: questions
Which YC batch was BioStack Platforms in?
BioStack Platforms was in Y Combinator's Spring 2026 batch (X26).
Is BioStack Platforms still active?
Y Combinator lists BioStack Platforms as active.
Who founded BioStack Platforms?
BioStack Platforms's founders, as listed on its YC page: Sanat Mishra (Founder/CEO), Parth Patwa (Founder/CTO).
Where is BioStack Platforms based?
BioStack Platforms lists San Francisco, CA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.